[go: up one dir, main page]

ATE247485T1 - Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus - Google Patents

Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus

Info

Publication number
ATE247485T1
ATE247485T1 AT94912727T AT94912727T ATE247485T1 AT E247485 T1 ATE247485 T1 AT E247485T1 AT 94912727 T AT94912727 T AT 94912727T AT 94912727 T AT94912727 T AT 94912727T AT E247485 T1 ATE247485 T1 AT E247485T1
Authority
AT
Austria
Prior art keywords
induction
peptides
vaccination
antibodies against
immunodeficiency virus
Prior art date
Application number
AT94912727T
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Tripep Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tripep Ab filed Critical Tripep Ab
Application granted granted Critical
Publication of ATE247485T1 publication Critical patent/ATE247485T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94912727T 1993-04-16 1994-04-15 Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus ATE247485T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4897693A 1993-04-16 1993-04-16
PCT/SE1994/000340 WO1994023746A1 (en) 1993-04-16 1994-04-15 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus

Publications (1)

Publication Number Publication Date
ATE247485T1 true ATE247485T1 (de) 2003-09-15

Family

ID=21957441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912727T ATE247485T1 (de) 1993-04-16 1994-04-15 Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus

Country Status (8)

Country Link
EP (1) EP0693938B1 (de)
JP (1) JPH09500096A (de)
AT (1) ATE247485T1 (de)
AU (2) AU6515394A (de)
CA (1) CA2160696C (de)
DE (1) DE69433057T2 (de)
ES (1) ES2202321T3 (de)
WO (1) WO1994023746A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2313376A (en) * 1996-05-22 1997-11-26 Diapharm Limited Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP)
WO1998009642A2 (en) * 1996-09-06 1998-03-12 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Therapeutic chemokine antagonists
US6982086B2 (en) 2000-02-04 2006-01-03 Duke University Human immunodeficiency virus immunogenic composition
WO2005097822A1 (en) * 2004-04-09 2005-10-20 University Of Manitoba Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
CN112745382B (zh) * 2021-01-22 2022-05-31 浙江辉肽生命健康科技有限公司 具有氨基酸结构ltvinqtqkenlr的生物活性肽及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2194836T3 (es) * 1990-09-27 2003-12-01 Tripep Ab Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
EP0594638A1 (de) * 1991-06-03 1994-05-04 Syntello Vaccine Development Ab Peptide zur induktion der t-zell aktivierung gegen hiv-1

Also Published As

Publication number Publication date
CA2160696A1 (en) 1994-10-27
WO1994023746A1 (en) 1994-10-27
DE69433057D1 (de) 2003-09-25
DE69433057T2 (de) 2004-06-03
JPH09500096A (ja) 1997-01-07
EP0693938B1 (de) 2003-08-20
CA2160696C (en) 2004-08-03
AU4832097A (en) 1998-03-12
ES2202321T3 (es) 2004-04-01
AU6515394A (en) 1994-11-08
EP0693938A1 (de) 1996-01-31

Similar Documents

Publication Publication Date Title
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
MA24638A1 (fr) Vaccin
MY136081A (en) Modified hiv - 1gag p17 peptide and immunogenic composition
EA200200724A1 (ru) Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич)
ES2307496T4 (es) Composiciones de vacuna, antígenos y péptidos de VIH
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
OA09802A (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
ATE134195T1 (de) Peptidfragmente von hiv
DE69327529D1 (de) Immunologisch mit HLA homologe HIV Protein Epitope
ATE247485T1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
KR950005326A (ko) 재조합 아데노바이러스 백신
ATE256745T1 (de) Therapeutischer- und präventivimpfstoff gegen hiv
WO2002045743A3 (en) Hcv vaccines
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
WO1991018618A3 (en) Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
Wahren et al. Immune responses to the HIV rev regulatory gene
Isola Studies on the antigenic structure of herpes simplex virus glycoprotein D.
Sia et al. Immune responses to a 104-mer synthetic peptide of the major internal protein, gag (p24) of the human immunodeficiency virus (HIV-1)
Pyle et al. Immune response to immunostimulatory complexes prepared from human immunodeficiency virus and the external envelope glycoprotein
DE68922540D1 (de) Vorläufer des Hüllenglykoproteins des HIV-2 Retrovirus und verwandte Antigene.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties